Mustang licenses immunodeficiency gene therapy from St. Jude

Mustang Bio Inc. (NASDAQ:MBIO) gained exclusive, worldwide rights to develop and commercialize an ex vivo lentiviral gene therapy

Read the full 186 word article

User Sign In